RPS8P6

Across TCGA pan-cancer cohorts, RPS8P6 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated RPS8P6 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RPS8P6 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPS8P6 expression acts as an unfavorable survival marker, although some lineages such as HNSC and KIRP show a favorable association.

STAD, MESO, and BLCA are the cancer types where RPS8P6 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Median	All	0.372	0.611	<.001	56	view →
MESO	OS	Tertile	All	0.246	0.570	.003	45	view →
BLCA	OS	Tertile	All	0.247	0.460	.014	42	view →
GBM	OS	Median	All	0.315	0.496	.001	27	view →
LGG	OS	Quartile	All	0.698	0.842	<.001	26	view →
KICH	OS	Tertile	II,III,IV	0.548	0.869	.021	23	view →
ESCA	DFS	Tertile	All	0.148	0.673	.040	18	view →
KIRC	DFS	Tertile	IV	0.217	0.603	.013	18	view →
UCS	OS	Tertile	All	0.287	0.602	.049	18	view →
SKCM	DFS	Tertile	II,III,IV	0.562	0.708	.026	12	view →
SARC	OS	Tertile	All	0.177	0.601	.025	12	view →
UVM	DFS	Tertile	III,IV	0.071	0.636	<.001	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

RPS8P6–STAD (OS)

Open the STAD breakdown →